Novo Holdings · Investments · 8634

AboutNovo GroupLeadershipResponsibilityNovo Nordisk Foundation

InvestmentsAreas

Seed InvestmentsVenture InvestmentsGrowth InvestmentsPrincipal InvestmentsPlanetary Health Investments

Capital Investments

StrategyRegions

North AmericaEuropeAsia

People & Careers

News & ReportsFacts & FiguresPress FAQMedia Library

Ray Therapeutics

Investment area

Venture Investments

Region

North America

Date of investment

April 2023

Investing to benefit people and the planet

Novo Holdings A/S

Tuborg Havnevej 19

2900 Hellerup Denmark

+45 3527 6500

Email: Info@novoholdings.dk

CVR# 24257630

Media Relations

Christian Mostrup Scheel

Head of Public Relations

Email: novoholdingsmedia@novo.dk

+45 3067 4805

Novo Holdings US Inc.*

Boston:

200 Clarendon Street, Floor 45

Boston, MA 02116 USA

San Francisco:

One Market Plaza, Floor 17 of the Steuart Tower

San Francisco, CA 94105 USA

+1 (415) 552-6686

Email: Info@novoholdings.dk

Novo Holdings Equity Asia Pte. Ltd.*

#40-01, 6 Battery Road

Singapore 049909

Email: Info@novoholdings.dk

Novo Holdings (UK office)

16 Berkeley Street

London W1J 8DZ

Email: Info@novoholdings.dk

Privacy notice Code of Conduct Whistleblower Articles of association Policy on data ethics Electronic invoicing Diversity policy

*Novo Ventures (US) Inc., Novo Holdings US Inc., comprising Novo Growth and Principal Investments, and Novo Holdings Equity Asia Pte. Ltd. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.

Follow us